Xenoestrogens: Mechanisms of action and some detection studies

Polish Journal of Veterinary Sciences

Volumn 11, Issue 3, 2008, Pages 263-269

  Slomczynska M ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Detection methods; Mechanism of action; Xenoestrogens

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; XENOBIOTIC AGENT;

ANIMAL; CELL LINE; DNA MICROARRAY; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PHYSIOLOGY; REVIEW; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELL LINE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS, NON-STEROIDAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, ESTROGEN; TRANSCRIPTION, GENETIC; XENOBIOTICS;

ANIMALIA; RODENTIA;

EID: 52649111610     PISSN: 15051773     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Balaguer P, Francois F, Comunale F, Fenet H, Boussioux AM, Pons M, Nicolas JC, Casellas C (1999) Reporter cell lines to study the estrogenic effects of xenoestrogens. Sci Total Environ 233: 47-56.
2. Chen JD, Evans RM (1995) A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377: 454-457.
3. Ciereszko R, Nynca A, Kraszewska O (2007) Phytoestrogens action of the ovary. In: Gonzales-Bulnes A (ed) Novel concepts in ovarian endocrinology. Transworld Research Network, India, pp 303-327.
4. Colburn T, Clement C (1992) Chemically induced alterations in sexual and functional development: the wildlife/human connection. Princeton Scientific Publishing, Princeton.
5. Couse JF, Bunch DO, Lindzey J, Schomberg DW, Korach KS (1999) Prevention of the Polycystic Ovarian Phenotype and Characterization of Ovulatory Capacity in the Estrogen Receptor-α Knockout Mouse. Endocrinology 140: 5855-5865.
6. Currie RA, Orphanides G, Moggs JG (2005) Mapping molecular responses to xenoestrogens through Gene Ontology and pathway analysis to toxicogenomic data. Reprod Toxicol 20: 433-440.
7. Diel P, Schmidt S, Vollmer G (2002) In vivo test systems fort he quantitative and qualitative analysis of the biological activity of phytoestrogens. J Chromatogr B Analyt Technol Biomed Life Sci, 777: 191-202.
8. Filardo EJ, Thomas P (2005) GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol Metab 16: 362-367.
9. Gadal F, Starzec A, Bozic C, Pillot-Brochet C, Malinge S, Ozanne V, Vicenzi J, Buffat L, Perret G, Iris F, Crepin M (2005) Integrative analysis of gene expression patterns predicts specific modulations of defined cell functions by estrogen and tamoxifen in MCF7 breast cancer. J Mol Endocrinol 34: 61-75.
10. Glidewell-Kenney C, Weiss J, Lee EJ, Pillai S, Ishikawa T, Ariazi EA, Jameson JL (2005) ERE-independent ER alpha target genes differentially expressed in human breast tumors. Mol Cell Endocrinol 245: 53-59.
11. Gonzalez FJ (2002) Transgenic models in xenobiotic metabolism and toxicology. Toxicology 181-182: 237-239.
12. Gray LE Jr, Kelce WR, Wiese T, Tyl R, Gaido K, Cook J, Klinefelter G, Desauliniers D, Wilson E, Zacharewski T, Waller C, Foster P, Laskey J, Reel J, Giesy J, Laws S, McLachlan J, Breslin W, Cooper R, Di Giulio R, Johnson R, Purdy R, Mihaich E, Safe S, Colborn T (1997) Endocrine Screening Methods Workshop Report: detection of estrogenic and androgenic hormonal and antihormonal activity for chemicals that act via receptor or steroidogenic enzyme mechanisms. Reprod Toxicol 11: 719-750.
13. Gutendorf B, Westerndorf J (2001) Comparison of an array of in vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens. Toxicology 166: 79-89.
14. Hall JM, Couse JF, Korach KS (2001) The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 276: 36869-36872.
15. Jorgensen M, Vendelbo B, Skakkebaek NE, Leffers H (2000) Assaying estrogenicity by quantitating the expression levels of endogenous estrogen-regulated genes. Environ Health Persp 108: 403-412.
16. Katzenellenbogen JA, O'Malley BW, Katzenellenbogen BS (1996) Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol Endocrinol 10: 119-131.
17. Kelly MJ, Qiu J, Wagner ER, Ronnekleiv OK (2002) Rapid effects of estrogen on G protein-coupled receptor activation of potassium channels in the central nervous system (CNS). J Steroid Biochem Mol Biol 83: 187-193.
18. Koohi MK, Ivell R, Walther N (2005) Transcriptional activation of the oxytocin promoter by oestrogens uses a novel non-classical mechanism of oestrogen receptor action. J Neuroendocrinol 17: 197-207.
19. Koohi MK, Walther N, Ivell R (2007) A novel molecular assay to discriminate transcriptional effects caused by xenoestrogens. Mol Cell Endocrinol 276: 45-54.
20. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139: 4252-4263.
21. Liu G, Schwartz JA, Brooks SC (1999) p53 down-regulates ER-responsive genes by interfering with the binding of ER to ERE. Biochem Bioph Res Co 264: 359-364.
22. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schuetz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM (1995) The nuclear receptor superfamily: The second decade. Cell 83: 835-839.
23. McEntry MW, Hullihen PL, Pedersen PL (1989) F0 "proton channel" of rat liver mitochondria. Rapid purification of a functional complex and a study of its interaction with the unique probe diethylstilbestrol. J Biol Chem 264: 12029-12036.
24. McGee EA, Hsueh AJ (2000) Initial and cyclic recruitment of ovarian follicles. Endocr Rev 21: 200-214.
25. McLachlan JA, Simpson E, Martin M (2006) Endocrine disrupters and female reproductive health. Best Pract Res Clin Endocrinol Metab 1: 63-75.
26. Meegan MJ, Lloyd DG (2003) Advances in the science of estrogen receptor modulation. Curr Med Chem 10: 181-210.
27. Miller KP, Borgeest C, Greenfeld C, Tomic D, Flaws JA (2004) In utero effects of chemicals on reproductive tissues in females. Toxicol Appl Pharm 198: 111-131.
28. Moggs JG, Tinwell H, Spunvay T, Chang HS, Pate I, Lim FL, Moore DJ, Soames A, Stuckey R, Currie R, Zhu T, Kimber I, Ashby J and Orphanides G (2004) Phenotypic anchoring of gene expression changes during estrogen-induced uterine growth. Environ Health Persp 112: 1589-1606.
29. Morrison AG, Callanan JJ, Evans NP, Aldrige TC, Sweeney T (2003) Effects of endocrine disrupting compounds on the pathology and oestrogen receptor alpha and beta distribution in the uterus and cervix of ewe lambs. Domest Anim Endocrin 25: 329-343.
30. Mueller SO (2002) Overview of in vitro tools to assess the estrogenic and antiestrogenic. activity of phytoestrogens. J Chromatogr B 777: 155-165.
31. Mueller SO, Korach KS (2001) Estrogen receptors and endocrine diseases, lessons from estrogen receptor knockout mice. Curr Opin Pharmacol 1: 613-619.
32. Mueller SO, Hall JM, Swope DL, Pedersen LC, Korach KS (2003) Molecular determinants of the stereoselectivity of agonist activity of estrogen receptors (ER) alpha and beta. J Biol Chem 278: 12255-12262.
33. Naciff JM, Daston GP (2004) Toxicogenomic approach to endocrine disrupters: identification of a transcript profile characteristic of chemicals with estrogenic activity. Toxicol Pathol 32 (Suppl 2): 59-70.
34. Nadal A, Ropero AB, Laribi O, Maillet M, Fuentes E, Soria B (2000) Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor alpha and estrogen receptor beta. Proc Natl Acad Sci USA 97: 11603-11608.
35. Orlando EF, Guillette Jr. LJ (2007) Sexual dimorphic responses in wildlife exposed to endocrine disrupting chemicals. Environ Res 104: 163-173.
36. Penza M, Bonetti E, Villa R, Ganzerla S, Bergonzi R, Biasiotto G, Caimi L, Apostoli P, Ciana P, Maggi A, Di Lorenzo D (2004) Whole body action of xenoestrogens with different chemical structures in estrogen reporter male mice. Toxicology 205: 65-73.
37. Pugazhendhi D, Sadler AJ, Darbre PD (2007) Comparison of the global gene expression profiles produced by methylparaben, n-butylparaben and 17beta-oestradiol in MCF7 human breast cancer cells. J Appl Toxicol 27: 67-77.
38. Ropero AB, Alonso-Magdalena P, Ripoll C, Fuentes E, Nadal A (2006) Rapid endocrine disruption: Environmental estrogen actions triggered outside the nucleus. J Steroid Biochem Mol Biol 102: 163-169.
39. Safe S, Wang F, Porter W, Duan R, McDougal A (1998) Ah receptor agonists as endocrine disruptors: antiestrogenic activity and mechanisms. Toxicol Lett 102-103: 343-347.
40. Safe S, Papineni S (2006) The role of xenoestrogenic compounds in the development of breast cancer. Trends Pharmacol Sci 27: 447-454.
41. Sarno JL, Kliman HJ, Taylor HS (2005) HOXA10, Pbx2, and Meis1 Protein Expression in the Human Endometrium: Formation of Multimeric Complexes on HOXA10 Target Genes. J Clin Endocr Metab 90: 522-528.
42. Shaw I, McCully (2002) A review of the potential impact of dietary endocrine disrupters on the consumer. Int J Food Sci Tech 37: 471-476.
43. Sheeler CQ, Dudley MV, Khan SA (2000) Environmental estrogens induce transcriptionally active estrogen receptor dimmers in yeast: activity potentiated by the coactivator RIP140. Environ Health Perspect 108: 97-103.
44. Shelby MD, Newbold RR, Tully D, Chae K, Davis VL (1996) Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo analysis. Environ Health Perspect 104: 1296-1300.
45. Shioda T, Chesnes J, Coser KR, Zou L, Hur J, Dean KL, Sonnenschein C, Soto AM, Isselbacher KJ (2006) Importance of dosage standardization for interpreting transcriptomal signature profiles: evidence from studies of Xenoestrogens. Proc Natl Acad Sci USA 103: 12033-12038.
46. Smith CC, Taylor HS (2007) Xenoestrogen exposure imprints expression of genes (Hoxa10) required for normal uterine development. FASEB J 21: 239-24.
47. Simoncini T, Varone G, Fornari L, Mannella P, Luisi M, Labrie F, Genazzani AR (2002) Genomic and nongenomic mechanisms of nitric oxide synthesis induction in human endothelial cells by a fourth-generation selective estrogen receptor modulator. Endocrinology 143: 2052-2061.
48. Singleton DW, Khan SA (2003) Xenoestrogen exposure and mechanism of endocrine disruption. Front Biosci 8: 110-118.
49. Słomczyńska M (2004) The effect of phytoestrogens on the reproductive tract. Pol J Vet Sci 7: 225-228.
50. Song RXD, Zhang Z, Santen RJ (2005) Estrogen rapid action via protein complex formation involving ERα and Src. Trends Endocrin Met 16: 347-353.
51. Sukocheva OA, Wang L, Albanese N, Pitson SM, Vadas MA, Xia P (2003) Sphingosine Kinase Transmits Estrogen Signaling in Human Breast Cancer Cells. Mol Endocrinol 17: 2002-2012.
52. Thompson BM, Cressey PJ, Shaw IC (2003) Dietary exposure to xenoestrogens in New Zealand. J Environ Monitor 5: 229-235.
53. Thompson L, Robb P, Serraino M, Cheung F (1991) Mammalian lignan production from various foods. Nutr Cancer 16: 43-52.
54. Turcotte JC, Hunt PJ, Blaustein JD (2005) Estrogenic effects of zearalenone on the expression of progestin receptors and sexual behavior in female rats. Horm Behav 47: 178-184.
55. Uzumcu M, Zachow R (2007) Developmental exposure to environmental endocrine disruptors: consequences within the ovary and on female reproductive function. Reprod Toxicol 23: 337-352.
56. Walsh DE, Dockery P, Doolan CM (2005) Estrogen receptor independent rapid non-genomic effects of environmental estrogens on [Ca2+]i in human breast cancer cells. Mol Cell Endocrinol 230: 23-30.
57. Wang W, Dong L, Saville B, Safe S (1999) Transcriptional Activation of E2F1 Gene Expression by 17{beta}-Estradiol in MCF-7 Cells Is Regulated by NF-Y-Sp1/Estrogen Receptor Interactions. Mol Endocrinol 13: 1373-1387.
58. Watson CS (2003) The identities of membrane steroid receptors and other proteins mediating nongenomic steroid action. Boston: Kluwer Academic Publishers.
59. Watson CS, Bulayeva NN, Wozniak AL, Alyea RA (2007) Xenoestrogens are potent activators of nongenomic estrogenic responses. Steroids 72: 124-134.
60. Witorsch RJ (2002) Endocrine disruptors: can biological effects and environmental risks be predicted? Regul Toxicol Pharm 36: 118-130.
61. Zheng J, Ramirez VD (2000) Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals. Brit J Pharmacol 130: 1115-1123.
62. Zhu Y, Bond J, Thomas P (2003) Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci USA 100: 2237-2242.